Why the study?
The authors sought to determine whether racial and socioeconomic disparities in the utilization of deep brain stimulation for Parkinson's disease have improved over time.
Are there racial and socioeconomic disparities in the utilization of deep brain stimulation for Parkinson's disease?
Are there racial and socioeconomic disparities in the utilization of deep brain stimulation for Parkinson's disease?
Significant racial and socioeconomic disparities persist in access to deep brain stimulation for Parkinson's disease, with White and privately insured patients being significantly more likely to receive the treatment.
Persistent racial disparities in DBS access for PD warrant targeted equity efforts; leaves open drivers of utilization trends in observational data.
We sought to determine whether racial and socioeconomic disparities in the utilization of deep brain stimulation (DBS) for Parkinson's disease (PD) have improved over time. We examined DBS utilization and analyzed factors associated with placement of DBS. The odds of DBS placement increased across the study period, whereas White patients with PD were 5 times more likely than Black patients to undergo DBS. Individuals, regardless of racial background, with 2 or more comorbidities were 14 times less likely to undergo DBS. Privately insured patients were 1.6 times more likely to undergo DBS. Despite increasing DBS utilization, significant disparities persist in access to DBS. ANN NEUROL 2022;92:246-254.
No takes yet. Share an insight, caveat, or question.
Cramer et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: